» Articles » PMID: 38020342

Management of Comorbidities in Difficult and Severe Asthma

Overview
Journal Breathe (Sheff)
Specialty Pulmonary Medicine
Date 2023 Nov 29
PMID 38020342
Authors
Affiliations
Soon will be listed here.
Abstract

Difficult-to-treat and severe asthma are challenging clinical entities. In the face of suboptimal asthma control, the temptation for clinicians is to reflexively escalate asthma-directed therapy, including increasing exposure to corticosteroids and commencement of costly but potent biologic therapies. However, asthma control is objectively and subjectively assessed based on measurable parameters (such as exacerbations or variability in pulmonary physiology), symptoms and patient histories. Crucially, these features can be confounded by common untreated comorbidities, affecting clinicians' assessment of asthma treatment efficacy.

Citing Articles

Eosinophil-Driven vs. Eosinophil-Associated Severe Asthma: Practical Implications for Target Treatment.

DAiuto V, Mormile I, Granata F, Romano A, Della Casa F, Mignogna G Int J Mol Sci. 2025; 26(4).

PMID: 40004192 PMC: 11855446. DOI: 10.3390/ijms26041729.


Maintenance oral steroids are not required in severe asthma.

Graham E, Eames C, Soe W, Fox L, Whitfield C, Kerley S ERJ Open Res. 2024; 10(6).

PMID: 39687394 PMC: 11647928. DOI: 10.1183/23120541.00568-2024.


The role of radiological imaging in the management of severe and difficult-to-treat asthma.

Aigbirior J, Almaghrabi A, Lafi M, Mansur A Breathe (Sheff). 2024; 20(2):240033.

PMID: 39015661 PMC: 11249838. DOI: 10.1183/20734735.0033-2024.

References
1.
Kopsaftis Z, Yap H, Tin K, Hnin K, Carson-Chahhoud K . Pharmacological and surgical interventions for the treatment of gastro-oesophageal reflux in adults and children with asthma. Cochrane Database Syst Rev. 2021; 5:CD001496. PMC: 8127576. DOI: 10.1002/14651858.CD001496.pub2. View

2.
Teodorescu M, Broytman O, Curran-Everett D, Sorkness R, Crisafi G, Bleecker E . Obstructive Sleep Apnea Risk, Asthma Burden, and Lower Airway Inflammation in Adults in the Severe Asthma Research Program (SARP) II. J Allergy Clin Immunol Pract. 2015; 3(4):566-75.e1. PMC: 4500672. DOI: 10.1016/j.jaip.2015.04.002. View

3.
Tolebeyan A, Mohammadi O, Vaezi Z, Amini A . Mepolizumab as Possible Treatment for Allergic Bronchopulmonary Aspergillosis: A Review of Eight Cases. Cureus. 2020; 12(8):e9684. PMC: 7486017. DOI: 10.7759/cureus.9684. View

4.
Tversky J, Lane A, Azar A . Benralizumab effect on severe chronic rhinosinusitis with nasal polyps (CRSwNP): A randomized double-blind placebo-controlled trial. Clin Exp Allergy. 2021; 51(6):836-844. DOI: 10.1111/cea.13852. View

5.
Moore W, Bleecker E, Curran-Everett D, Erzurum S, Ameredes B, Bacharier L . Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin Immunol. 2007; 119(2):405-13. PMC: 2837934. DOI: 10.1016/j.jaci.2006.11.639. View